SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0000950170-22-015513
Filing Date
2022-08-08
Accepted
2022-08-08 16:07:25
Documents
61
Period of Report
2022-06-30

Document Format Files

Seq Description Document Type Size
1 10-Q igms-20220630.htm   iXBRL 10-Q 2832905
2 EX-31.1 igms-ex31_1.htm EX-31.1 18958
3 EX-31.2 igms-ex31_2.htm EX-31.2 17278
4 EX-32.1 igms-ex32_1.htm EX-32.1 11323
5 EX-32.2 igms-ex32_2.htm EX-32.2 11303
  Complete submission text file 0000950170-22-015513.txt   8079376

Data Files

Seq Description Document Type Size
6 XBRL TAXONOMY EXTENSION LABEL LINKBASE DOCUMENT igms-20220630_lab.xml EX-101.LAB 452798
7 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE DOCUMENT igms-20220630_pre.xml EX-101.PRE 336041
8 XBRL TAXONOMY EXTENSION CALCULATION LINKBASE DOCUMENT igms-20220630_cal.xml EX-101.CAL 50473
9 XBRL TAXONOMY EXTENSION DEFINITION LINKBASE DOCUMENT igms-20220630_def.xml EX-101.DEF 218575
10 XBRL TAXONOMY EXTENSION SCHEMA DOCUMENT igms-20220630.xsd EX-101.SCH 54630
55 EXTRACTED XBRL INSTANCE DOCUMENT igms-20220630_htm.xml XML 1165478
Mailing Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043
Business Address 325 E MIDDLEFIELD ROAD MOUNTAIN VIEW CA 94043 650-965-7873
IGM Biosciences, Inc. (Filer) CIK: 0001496323 (see all company filings)

IRS No.: 770349194 | State of Incorp.: DE | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 001-39045 | Film No.: 221144376
SIC: 2834 Pharmaceutical Preparations